Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs LMWH for Thrombosis Prevention in Cancer Patients After Femoral Venepuncture
NCT03282643Phase 2Completed
- Sponsor
- Capital Medical University
- Start
- Feb 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rivaroxaban in deep vein thrombosis (DVT), sponsored by Capital Medical University. Started Feb 2016; status: completed.
02
Drugs
rivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT03282643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03282643.